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Pseudomonas Aeruginosa- and IL-1b-Mediated
Induction of Human b-Defensin-2 in Keratinocytes
Is Controlled by NF-jB and AP-1
Kai Wehkamp1, Lars Schwichtenberg1, Jens-Michael M. Schro¨der1 and Ju¨rgen Harder1
Human b-defensin-2 (hBD-2) is an inducible epithelial peptide antibiotic involved in cutaneous defense.
Expression of hBD-2 in keratinocytes is strongly induced by IL-1b and culture supernatants of Pseudomonas
aeruginosa (PA). The use of an IL-1 receptor antagonist revealed that PA-mediated induction of hBD-2 is not
dependent on IL-1. Luciferase gene reporter experiments, demonstrated that a 2,338 bp promoter fragment of
hBD-2 containing three putative NF-kB as well as one activator protein-1 (AP-1) binding site was strongly
activated by IL-1b and PA. Mutation of all NF-kB binding sites together with mutation of the AP-1 binding site
completely abolished hBD-2 promoter activation by IL-1b and PA. Treatment with the NF-kB inhibitor Helenalin
as well as with the c-Jun N-terminal kinase (JNK) inhibitor SP600125 and the p38 mitogen-activated protein
kinase inhibitor SB 202190 blocked hBD-2 induction by IL-1b and PA. PD 98059, a selective inhibitor of
extracellular signal-regulated kinase 1/2 demonstrated no significant influence. Transcription factor ELISAs
indicated that the NF-kB heterodimer p50–p65 binds to all three NF-kB sites in the hBD-2 promoter upon
stimulation of primary keratinocytes with IL-1b and PA. We conclude that the activation of NF-kB (p50–p65) and
AP-1 are crucial events for induction of hBD-2 in keratinocytes upon IL-1b and PA stimulation.
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INTRODUCTION
Human skin is in permanent contact with various potential
pathogenic microorganisms. To overcome these microbial
threats, the skin has developed a chemical defense system
that is based on the production of various antimicrobial
proteins. The in vivo relevance of antimicrobial proteins in
cutaneous host defense has been demonstrated in a mouse
model. Mice, deficient in the expression of the cathelicidin
CRAMP (the mouse homolog of the human cathelicidin LL-
37), were more susceptible to skin infections caused by group
A Streptococcus. Group A Streptococcus mutants resistant to
CRAMP resulted in more severe skin infections in normal
mice (Nizet et al., 2001). Recently, in vivo experiments with
neutralizing anti-psoriasin antibodies identified psoriasin
(S100A7) as a key factor in the resistance of human skin
against E. coli (Glaeser et al., 2005).
Psoriatic skin represents a particularly rich source of
antimicrobial proteins (Harder and Schroeder, 2005), thus
offering an explanation as to why patients with psoriasis
suffer fewer cutaneous bacterial infections than expected
(Christophers and Henseler, 1987). In contrast, the expression
of the antimicrobial proteins human b-defensin-2 (hBD-2),
hBD-3, and LL-37 is decreased in acute and chronic lesions
from patients suffering from atopic dermatitis (Ong et al.,
2002; Nomura et al., 2003). It is believed that the low
expression of antimicrobial proteins may at least partially
account for the increased susceptibility of patients with
atopic dermatitis to skin infection.
hBD-2 was the first inducible human antimicrobial protein
and was originally isolated from lesional psoriatic skin
(Harder et al., 1997). hBD-2 belongs to the b-defensin family,
a group of small (4–5 kDa), cationic peptide antibiotics that
were first discovered in cattle (Diamond et al., 1991). hBD-2
exhibits a broad spectrum of antimicrobial activity and
its capacity to kill bacteria in vivo has been demonstrated
in a mouse gene therapy study with hBD-2-transfected
tumor cells. Following a bacterial infection, mice with
hBD-2-bearing tumors bore fewer viable bacteria than
controls (Huang et al., 2002). Expression of hBD-2 in
epithelial cells is induced by proinflammatory cytokines
and bacteria (Schroeder and Harder, 1999). The inducibility
of hBD-2 may explain why hBD-2 expression is increased
in inflammed skin (Liu et al., 1998). Endogenous proin-
flammatory cytokines like IL-1 and exogenous stimuli
such as Pseudomonas aeruginosa (PA) have proven to
be the most effective inducers of hBD-2 in keratinocytes
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Little has been described to date regarding the gene
regulation of hBD-2 induction by either IL-1 or PA in
keratinocytes. Therefore, our goal was to characterize the
signaling pathways involved in hBD-2 induction in response
to its strong inducers PA and IL-1b.
RESULTS
Induction of hBD-2 in primary keratinocytes by PA and IL-1b
Primary keratinocytes were treated with either culture super-
natants of PA or IL-1b, and hBD-2 expression was measured
by real-time PCR and ELISA. As expected, PA as well as IL-1b
induced hBD-2 gene and protein expression in primary
keratinocytes (Figure 1a and b). To test whether hBD-2
induction correlates with hBD-2 promoter activation,
2,338 bp of the hBD-2 promoter was ligated in front of the
firefly luciferase gene and this construct was used to
transiently transfect primary keratinocytes. Stimulation of
the transfected keratinocytes with PA or IL-1b led to a strong
increase in luciferase activity, indicating activation of the
hBD-2 promoter (Figure 2b and c).
Induction of hBD-2 expression by PA is not mediated by
autocrine IL-1 induction
Our analyses revealed no significant differences between IL-
1b- and PA-mediated hBD-2 induction. Therefore, we
wondered whether PA induces hBD-2 by an autocrine IL-
1b- or IL-1a-mediated mechanism. We used an IL-1 receptor
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Figure 1. HBD-2 induction by PA is not mediated via IL-1. Primary
keratinocytes were incubated with or without a specific IL-1-receptor
antagonist (IL-1ra, 300 ng/ml) for 1 hour and subsequently stimulated with IL-
1b or PA for 10 hours. (a) hBD-2 mRNA expression was analyzed by real-time
RT-PCR and normalized to the expression of glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) mRNA. The relative transcript level was further
normalized with the unstimulated control, which was assigned the value 1.
(b) hBD-2 expression was measured in cell culture supernatants using an
hBD-2-ELISA. Data are means7SD of one representative experiment of three,
each carried out in triplicate samples. Differences between IL-1ra-treated and
-untreated cells were analyzed by two-tailed, nonpaired t-test, with Po0.05
indicative of statistical significance (NS¼ not significant).
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Figure 2. Mutation of NF-jB and AP-1 binding sites inhibits IL-1b- and
PA-mediated hBD-2 induction. (a) The hBD-2 promoter constructs. Nucleotide
positions are marked relative to the hBD-2 transcription start. Three NF-kB
sites and one AP-1 site in the hBD-2 promoter (2,338 to 1 bp) linked to the
luciferase gene were mutated in different combinations. (b and c) Primary
keratinocytes were transfected with the wild-type (2,338-luc) or mutated
hBD-2-promoter-luciferase plasmids together with an internal control (renilla
luciferase expression plasmid). After transfection, cells were stimulated with
IL-1b (b) or supernatants of PA (c) for 10 hours and relative hBD-2 promoter
activity was determined as a ratio between firefly and renilla luciferase
activity. Data are means7SD of one representative experiment of three, each
carried out in triplicate samples.
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antagonist (IL-1ra) to determine the influence of IL-1 in
keratinoctyes stimulated with PA. Primary keratinocytes
preincubated with IL-1ra and subsequently stimulated with
PA showed no significant reduction in hBD-2 induction as
compared to non-IL-1ra-treated cells (Figure 1a and b).
Abolishment of IL-1b-mediated hBD-2 expression by IL-1ra
served as a positive control (Figure 1a and b).
NF-jB and AP-1 binding sites in the hBD-2 promoter are
required for PA- and IL-1b-mediated hBD-2 induction
To analyze the functional importance of putative binding
sites for the transcription factors NF-kB and activator protein-
1 (AP-1) on PA- and IL-1b-mediated induction of hBD-2, we
generated different hBD-2-promoter-luciferase constructs
containing mutations of the three NF-kB binding sites
(positions 205 to 186, 596 to 572, and 2,193 to
2,184) and the AP-1 binding site (positions 127 to 121)
(Figure 2a). Interestingly, the influence of these four putative
binding sites on hBD-2 induction in primary keratinocytes
turned out to be similar for PA as well as IL-1b stimulation
(Figure 2b and c). Mutation of all three NF-kB sites as well as
mutation of the three NF-kB sites together with the AP-1 site
almost completely abolished PA- and IL-1b-mediated hBD-2
promoter activation. Separate mutations of the three NF-kB
binding sites revealed that the first proximal NF-kB binding
site (positions 205 to 186) is of major importance for the
IL-1b- and PA-mediated hBD-2 induction followed by the
second (positions 596 to 572) and the third (positions
2,193 to 2,184) NF-kB binding site (Figure 2b and c). The
potential AP-1 binding site (positions 127 to 121) is also
crucial for full IL-1b- and PA-mediated hBD-2 induction
because its mutation efficiently reduced hBD-2 promoter
activation (Figure 2b and c).
Inhibitors of MAP kinases and NF-jB pathways block PA- and
IL-1b-mediated hBD-2 induction
To verify the influence of the transcription factors NF-kB and
AP-1 on PA- and IL-1b-mediated hBD-2 induction, we used
inhibitors of the three AP-1 activating mitogen-activated
protein kinase (MAP) kinase cascades (extracellular signal-
regulated kinase 1/2 pathway, c-Jun N-terminal kinase (JNK)
pathway, and p38 pathway) as well as the NF-kB inhibitor
Helenalin. Treatment with SB 202190, a specific p38 MAP
kinase inhibitor, as well as treatment with SP600125, a
selective inhibitor of JNK, strongly reduced hBD-2 protein
induction by PA and IL-1b in primary keratinocytes (Figure 3).
PD 98059, a selective inhibitor of extracellular signal-
regulated kinase 1/2 did not decrease IL-1b-mediated hBD-2
induction but moderately reduced PA-mediated hBD-2
induction (Figure 3). Furthermore, hBD-2 gene induction by
PA or IL-1b was also blocked by treatment of primary
keratinocytes with the NF-kB inhibitor Helenalin (Figure 3).
To measure potential cytotoxic effects of the inhibitors on the
keratinocytes, we determined the release of lactate dehy-
drogenase using the Cytotoxicity Detection Kit (Roche
Diagnostics, Mannheim, Germany). The MAP kinase inhibi-
tors showed no significant lactate dehydrogenase release and
Helenalin showed only a very low increase in lactate
dehydrogenase release (5%), indicating no major cytotoxic
effects. In addition, expression of the housekeeping gene
glyceraldehyde-3-phosphate dehydrogenase was not affected
by the inhibitors, whereas changes in hBD-2 gene expression
correlated with hBD-2 protein release (data not shown).
Identification of NF-jB family members p65 and p50 bound to
the three NF-jB binding sites in the hBD-2 promoter upon
stimulation with PA or IL-1b
Since the NF-kB transcription factor consists of homo- or
heterodimeric subunits of the NF-kB/Rel family, we deter-
mined the NF-kB subunits bound to the hBD-2 promoter in
IL-1b and PA-stimulated primary keratinocytes. Using a
transcription factor ELISA, we could show that binding of
the subunits p65 and p50 to all three NF-kB binding sites of
the hBD-2 promoter was strongly increased in IL-1b- and PA-
stimulated keratinoctyes (Figure 4). Binding of the NF-kB
subunits p52, RelB, and C-Rel was not markedly increased
(Figure 4).
DISCUSSION
Recent studies have indicated that the production of skin-
derived antimicrobial proteins provides a powerful defense
mechanism to protect the epidermis against harmful micro-
organisms. Interestingly, the production of antimicrobial
proteins in keratinocytes can be activated through endogen-
ous signals such as proinflammatory cytokines and growth
factors as well as through contact with bacteria (Ong et al.,
2002; Nomura et al., 2003; Sorensen et al., 2003, 2005;
Harder et al., 2004). hBD-2 represents one member of those
inducible endogenous antimicrobial proteins. Expression of
hBD-2 in keratinocytes is strongly induced by the proin-
flammatory cytokine IL-1b and bacteria such as PA (Sorensen
et al., 2003; Harder et al., 2004). In agreement with these
findings, we show here that IL-1b as well as supernatant of
cultured PA activated a hBD-2-promoter-luciferase construct
transfected in primary keratinocytes. Recent studies suggested
that the epidermal response to microbe-derived molecules is
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Figure 3. Inhibition of P. aeruginosa- or IL-1b-mediated hBD-2 induction in
primary keratinocytes by NF-jB, JNK, and p38-MAP kinase inhibitor.
Primary keratinocytes were preincubated for 1 hour with inhibitors for NF-kB
and the MAP kinases, extracellular signal-regulated kinase (ERK)1/2, JNK, and
p38. Subsequent stimulation was performed using supernatants of PA or IL-1b
for 10 hours. hBD-2 expression was measured in cell culture supernatants
using an hBD-2-ELISA. Data are means7SD of one representative experiment
of three, each carried out in triplicate samples. **Significantly different from
stimulated cells without inhibitor treatment (Po0.01, Student’s t-test).
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potently amplified by monocytes and lymphocytes through
IL-1-mediated signaling, leading to an increase in the
production of hBD-2 by keratinocytes (Liu et al., 2003). As
it is known that keratinocytes are a rich source of IL-1 (Kupper
and Groves, 1995; Grone, 2002), one may speculate that the
production of hBD-2 by keratinocytes upon contact with PA
is mediated by the release of IL-1 in an autocrine or paracrine
manner. To investigate this possible IL-1-dependent induc-
tion of hBD-2 by PA, we used an IL-1 receptor antagonist.
Treatment of the keratinocytes with the IL-1 receptor
antagonist completely abolished IL-1b-mediated hBD-2
induction, whereas PA-mediated hBD-2 induction was not
significantly affected. These data suggest that PA does not
induce hBD-2 expression in keratinocytes through the
autocrine or paracrine production of IL-1.
It is known that both IL-1b and bacteria can activate the
transcription factors NF-kB and AP-1 (Hobbie et al., 1997;
Florin et al., 2004; Vitiello et al., 2004; Kelly and Conway,
2005). Since the promoter region of the hBD-2 gene contains
binding sites for NF-kB as well as for AP-1, we analyzed the
relevance of these binding sites for both IL-1b- and PA-
mediated hBD-2 induction. Indeed, mutation of all three
NF-kB sites almost completely blocked hBD-2 promoter
activation upon treatment with either IL-1b or PA, indicating
that NF-kB play a crucial role in the regulation of IL-1b- and
PA-mediated hBD-2 gene induction. The importance of
NF-kB in the signal transduction pathway leading to hBD-2
gene induction by IL-1b and PA was further confirmed by the
observation that the specific NF-kB inhibitor Helenalin
abolished hBD-2 induction upon treatment of the keratinocytes
with either IL-1b or PA. The observation that hBD-2 induction
in keratinocytes by PA or IL-1b is dependent on NF-kB is
consistent with previous reports showing that NF-kB is a
transcription factor essential for induction of hBD-2 by various
bacteria. For example, induction of hBD-2 in colon or gastric
epithelial cells by Salmonella, E. coli, and Helicobacter pylori
is mediated by NF-kB (O’Neil et al., 1999; Ogushi et al., 2001;
Wada et al., 2001; Wehkamp et al., 2004).
Separate mutations of the three NF-kB binding sites in the
hBD-2 promoter revealed that all three NF-kB binding sites
are essential for full induction of the hBD-2 gene upon IL-1b
and PA stimulation. In particular, the first proximal NF-kB
binding site (positions 205 to 186) plays an important role
for IL-1b- and PA-mediated hBD-2 induction in keratinocytes
because mutation of this site strongly inhibited hBD-2
promoter activation upon IL-1b and PA treatment. We
observed the binding of the NF-kB subunits p65 and p50 to
all three NF-kB binding sites, indicating that the IL-1b- and
PA-mediated induction of hBD-2 involved the binding of the
heterodimer p65–p50 to all three NF-kB binding sites of the
hBD-2 promoter. The binding of the NF-kB heterodimer
p65–p50 to the first proximal NF-kB binding site in the hBD-2
promoter has also been observed in mononuclear phagocytes
stimulated with LPS and in A549 lung epithelial cells
stimulated with IL-1b or tumor necrosis factor-a (Tsutsumi-
Ishii and Nagaoka, 2002, 2003). In contrast, Salmonella
enteritidis flagella filament protein induced hBD-2 expression
in Caco-2 cells via p65–p65 homodimer binding to the first
proximal NF-kB binding site (Ogushi et al., 2001). In gastric
MKN45 cells, only the p65–p65 homodimer was found to
bind to the NF-kB site of the hBD-2 promoter upon H. pylori
stimulation (Wada et al., 2001). Therefore, it seems that the
first proximal NF-kB binding site is able to bind both the
p65–p65 homodimer as well as the p65–p50 heterodimer. All
these reports together indicate that the first proximal NF-kB
binding site represents the crucial region of the hBD-2
promoter with regard to NF-kB-mediated hBD-2 induction.
Recent studies have reported on hBD-2 induction by
bacteria without the involvement of the transcription factor
NF-kB. For example, Dale and co-workers demonstrated that
hBD-2 induction with a periodontal bacterium Fusobacter-
ium nucleatum in human gingival epithelial cells was not
blocked by NF-kB inhibitors. They found that hBD-2
induction by F. nucleatum is regulated via the p38 and JNK
kinase pathways and speculated that the activation of the p38
and JNK may regulate gene expression of hBD-2 through
transcription factor AP-1 (Krisanaprakornkit et al., 2002). As
shown here, the proximal AP-1 binding site in the hBD-2
promoter is crucial for full induction of hBD-2 in keratino-
cytes by IL-1b and PA. It is known that AP-1 can be activated
by different MAP kinase pathways including the ERK, the JNK
pathway, and the p38 MAP kinase (Whitmarsh and Davis,
1996). Using specific inhibitors for these three MAP kinase
pathways, we found that both the p38 and JNK kinase
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Figure 4. Differential binding of p50, p52, p65, RelB, and C-Rel to three
NF-jB binding sites in hBD-2 promoter. Nuclear extracts of IL-1b- (a) or
PA- (b) treated primary keratinocytes were incubated with different
oligonucleotides each containing one of the putative NF-kB sites of the hBD-2
promoter (NF-kB-I at positions 205 to 186, NF-kB-II at positions 596 to
572, and NF-kB-III at positions 2,193 to 2,184). Binding of NF-kB
subunits was analyzed using a transcription factor ELISA with specific
antibodies for RelA, RelB, C-Rel, p50, and p52. Bars indicate the optical
density (OD) at 450 nm and values indicate the relative (%) OD increment of
IL-1b- (a) or PA- (b) treated cells compared to untreated control cells. Similar
results were obtained with primary keratinocytes from two other donors.
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pathways are involved in the induction of hBD-2 by both IL-
1b and PA in keratinocytes.
It is an interesting observation that functional bindings
sites for both NF-kB and AP-1 are required for full hBD-2
promoter activation upon stimulation with IL-1b as well with
PA. This indicates that endogenous stimuli such as IL-1b as
well as exogenous stimuli like bacterial products can activate
the same signal transduction pathways. It has been shown
that Toll-like receptors respond to different microbial
products, and the signaling pathways activated (in particular
NF-kB, p38, and JNK kinase pathways) are very similar to that
generated by activation of the IL-1 receptor (O’Neill, 2002).
Furthermore, it has been demonstrated that keratinocytes
express Toll-like receptors (Baker et al., 2003; Mempel et al.,
2003; Pivarcsi et al., 2003), and Nagy et al. (2005) have
shown that Propionibacterium acnes-mediated hBD-2 induc-
tion in keratinocytes is Toll-like receptor-2 and Toll-like
receptor-4 dependent. Therefore, one could speculate that
induction of hBD-2 through PA may be meditated by the
activation of Toll-like receptors. However, this hypothesis
remains to be proven.
It is likely that other transcription factors may participate in
the hBD-2 induction by IL-1b and PA in keratinocytes.
However, our data clearly demonstrate that activation and
binding of NF-kB and AP-1 to the hBD-2 promoter are
essential events in the signal cascade that mediate the
upregulation of hBD-2 through its strong inducers PA and
IL-1b. Dysregulation of this cascade may lead to insufficient
inducible expression of hBD-2 in skin and may increase the
risk of cutaneous infections. A better understanding of the
pathways leading to induction of antimicrobial proteins may
result in therapeutical approaches that enhance the innate
epithelial defense system.
MATERIALS AND METHODS
Cell culture and stimulation
Foreskin-derived keratinocytes were isolated from neonatal foreskins
and cultured in keratinocyte growth medium (Clonetics, San Diego,
CA) in 5% CO2 at 371C as described (Wiedow et al., 1998). The
study was conducted according to the Declaration of Helsinki
Principles, and the isolation of human keratinocytes from foreskin
was approved by the Institutional Review Board of the University of
Kiel. For stimulation experiments, cells were seeded in 12-well tissue
culture plates (4 cm2/well; BD Biosciences, San Jose, CA) and used at
70–80% confluence. Cells were stimulated with IL-1b (20 ng/ml) or
supernatants of PA (20ml/ml) for 10 hours. The MAP kinase inhibitors
PD 98059, SB 202190, and SP600125 as well as the NF-kB inhibitor
Helenalin were dissolved in DMSO. These inhibitors were added
directly to the culture medium at a final concentration of 20 mM,
1 hour prior to stimulation. The IL-1ra was dissolved in water and
added to the culture medium at a final concentration of 300 ng/ml,
1 hour prior to stimulation.
IL-1b and IL-1ra were purchased from Cell Concepts (Freiburg,
Germany) and the inhibitors were from Calbiochem (Darmstadt,
Germany). Supernatants of PA (ATCC 33354) were generated by
centrifugation (6,000 g, 15 minutes) of a 50 ml overnight culture
grown at 371C in trypticase–soy broth. The harvested bacteria were
resuspended in 50 ml MG medium (40 mM K2HPO4, 30 mM glucose,
22 mM KH2PO4, 7 mM NH4SO4, and 0.5 mM MgSO4) and incubated
in 500 cm2 triple flasks (Nunc, Wiesbaden, Germany) at 371C for
24 hours. After incubation, bacteria were removed by centrifugation
(6,000 g, 15 minutes) and the resulting supernatant was sterile
filtered (0.2 mm) and stored until use at 201C.
Real-time PCR
After stimulation, total RNA was isolated and reverse transcribed
using standard reagents (Gibco-BRL, Karlsruhe, Germany). The
resulting cDNA served as a template in a real-time PCR reaction in
a fluorescence temperature cycler (LightCycler, Roche Molecular
Biochemicals, Mannheim, Germany). Amplification of hBD-2 and of
the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase
was performed as described previously (Harder et al., 2004).
A standard curve was plotted for each primer set with the critical
threshold cycle (Ct) values obtained from amplification of 10-fold
dilutions of cDNA to calculate the PCR efficiency of the primer set.
Glyceraldehyde-3-phosphate dehydrogenase was used as an internal
reference to normalize the target transcripts and a mathematical
model described by Pfaffl (2001) was used to determine the relative
quantification of hBD-2 gene expression compared with the
glyceraldehyde-3-phosphate dehydrogenase gene expression.
hBD-2 reporter plasmid construction
To analyze hBD-2 promoter activity, 2,338 bp of the human hBD-2
promoter was amplified using the primers 50-CAGTACAGCAG
CAGTGATAG-30 and 50-GGGGAGGACATCAAGCCTT-30. The am-
plification product was subcloned into the promoterless pGL3-basic
firefly luciferase vector (Promega, Madison, WI) to generate an hBD-
2-2,338-luc reporter plasmid.
The functional role of putative binding sites for the transcription
factor NF-kB as well as for the transcription factor AP-1 in the hBD-2
promoter region was studied by site-directed mutagenesis. The
‘‘QuickChangeTM XL Site-Directed Mutagenesis Kit’’ (Stratagene, La
Jolla, CA) was used as indicated by the supplier for the introduction
of mutations in the hBD-2-2,338-luc plasmid. The first two of the
three putative NF-kB binding sites at positions 205 to 186, 596
to 572 as well as the putative AP-1 binding site at positions 127 to
121 were mutated using mutant primers as described (Tsutsumi-Ishii
and Nagaoka, 2003; Wehkamp et al., 2004). For mutating the third
NF-kB binding site (positions 2,193 to 2,184), the following
primers were used: sense 50-gtcacaccat cttttgttac tttACgCGtt ccccagc
tat gttcaataat-30 and antisense 50-attattgaac atagctgggg aaCGcGTaaa
gtaacaaaag atggtgtgac-30. The resulting hBD-2-pGL3 plasmids con-
taining mutated NF-kB and AP-1 binding sites were termed NF-kB-
mut1-luc (containing one mutated NF-kB binding site at positions
205 to 186), NF-kB-mut2-luc (containing one mutated NF-kB
binding site at positions 596 to 572), NF-kB-mut3-luc (containing
one mutated NF-kB binding site at positions 2,193 to 2,184), NF-
kB-mut1þ 2þ 3-luc (containing three mutated NF-kB binding sites),
AP1-mut-luc (containing a mutated AP-1 binding site), and AP-
1þNF-kB-mut-luc (containing three mutated NF-kB binding sites and
a mutated AP-1 binding site). An overview showing the used promoter
constructs is given in Figure 2a.
Transfection and determination of promoter activity
For hBD-2 promoter studies, keratinocytes were seeded in 12-well
plates (BD Biosciences) and used for transfection at 60–80%
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confluence. Cells were transfected with 0.5mg of the indicated hBD-2
reporter plasmids and 0.025mg of an internal control renilla luciferase
expression plasmid (phRG-TK; Promega) using 1ml transfection
reagent Fugene 6 (Roche Diagnostics Gmbh, Mannheim, Germany)
according to the manufacturer’s instructions. Twenty-four hours after
transfection, cells were stimulated with the indicated stimulus for
10 hours in fetal calf serum-free medium. After stimulation, cells were
harvested with 500ml passive lysis buffer (Promega), and firefly
luciferase activity from hBD-2-pGL3 reporter vector and renilla
luciferase activity were measured by the Dual Luciferase assay system
(Promega) on a TD-20/20 luminometer (Turner Design, Sunnyvale,
CA). Promoter activity was reported as the ratio between firefly and
renilla luciferase activities in each sample.
hBD-2-ELISA
For ELISA, 96-well immunoplates (MaxiSorpTM, Nunc, Roskilde,
Denmark) were coated at 41C for 20 hours with 50 ml (1mg/ml) goat
anti-hBD-2 antibody (Cell Concepts, Umkirch, Germany) in 0.05 M
carbonate buffer, pH 9.6. Subsequently, wells were blocked with
200ml 1% BSA in phosphate-buffered saline (PBS) for 10 minutes at
room temperature. After washing three times with 200 ml PBSþ 0.1%
Tween 20, 100 ml/well of cell culture supernatants and serial
dilutions of natural skin-derived hBD-2 in cell culture medium were
incubated for 30 minutes at room temperature. Plates were washed
thrice with PBSþ 0.1% Tween 20, and wells were incubated for
30 minutes at room temperature with 50 ml of biotinylated goat anti-
hBD-2 antibody (Cell Concepts) diluted 1:2,500 to 0.2 mg/ml in
PBSþ 0.1% Tween 20. Plates were washed again three times with
PBSþ 0.1% Tween 20 and filled with 50ml/well of Streptavidin–POD
(Roche Diagnostics; 1:10,000 in PBSþ 0.1% Tween 20). The plates
were then incubated for 30 minutes at room temperature, washed
three times as described above, and incubated with 2,20-azino-bis-3-
ethylbenzthiazoline-6-sulfonic acid (Roche Diagnostics) as the
development agent for 15 minutes at room temperature in the dark.
Absorbance was measured at 405 nm with a multichannel photo-
meter (Sunrise; Tecan, Crailsheim, Germany).
Transcription factor ELISA
Primary keratinocytes stimulated with PA culture supernatant or IL-
1b were harvested and nuclear extract was prepared using standard
reagents (NucBuster, Novagen, Germany). For transcription factor
ELISAs, reagents of two commercially available transcription factor
ELISA kits (TransAM, Active Motif, Rixensart, Belgium and NoShift,
Novagen/Merck Biosciences, Bad Soden, Germany) were used. The
96-well streptavidin plates (Merck Biosciences) were coated with
double-stranded 30-biotinylated oligonucleotides, matching the
sequences of one of the three putative NF-kB binding sites in the
hBD-2 promoter (NF-kB-I: 50-gaggaagggattttctggggtttcctgagtc-30; NF-
kB-II: 50-gaagatggggagtttcaggggaactttcacataaa-30; NF-kB-III: 50-actttg
ggacttccccagct-30). This binding step was performed, using the
preparation and binding solution supplied with the NoShift-Kit
(Novagen), according to the manufacturer’s instructions. Subse-
quently, reagents of the TransAM-NF-kB-Kit (Active Motif) were used
according to the manufacturer’s protocol using a self-coated
streptavidin plate. Briefly, the bound oligonucleotides were first
incubated with 5mg of the indicated nuclear extract and treated with
a primary rabbit antibody against the NF-kB subunits p50, p52, p65,
B-Rel, or RelC (provided with TransAM-NF-kB-Kit, Active Motif).
After incubation with a secondary horseradish peroxidase-labeled
anti-rabbit antibody (Active Motif) and development with the
supplied developing reagent, absorbance was measured at a
wavelength of 450 nm. This was referenced to 610 nm in a
multichannel photometer (Sunrise; Tecan, Crailsheim, Germany).
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